Resource utilization and hospital cost of HIV/AIDS care in Italy in the era of highly active antiretroviral therapy

AIDS Care - Psychological and Socio-Medical Aspects of AIDS/HIV

Volumn 13, Issue 6, 2001, Pages 733-741

  Garattini, L ^a   Tediosi, F ^a   Di Cintio, E ^a   Yin, D ^b   Parazzini, F ^a  

^a MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

^b MERCK RESEARCH LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; AIDS RELATED COMPLEX; ARTICLE; CLINICAL TRIAL; DISEASE COURSE; ECONOMIC ASPECT; FEMALE; HEALTH CARE UTILIZATION; HEALTH ECONOMICS; HOSPITAL COST; HOSPITALIZATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; ITALY; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; OUTPATIENT CARE; PRIORITY JOURNAL; RISK FACTOR;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ADULT; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CD4 LYMPHOCYTE COUNT; DISEASE PROGRESSION; DRUG COSTS; FEMALE; HEALTH RESOURCES; HIV INFECTIONS; HOSPITAL COSTS; HUMANS; ITALY; MALE; PROSPECTIVE STUDIES;

EID: 0035662880     PISSN: 09540121     EISSN: None     Source Type: Journal    
DOI: 10.1080/09540120120076896     Document Type: Article

References (23)

1. Modelling the potential economic impact of viral load-driven triple drug combination antiretroviral therapy
2. The use and cost of HIV service provision in England in 1996
3. The cost of health care for HIV-positive patients
4. HAART (Zidovudina Lamivudina, Indinavir): Analisi dei costi in una popolazione di pazienti HIV positivi con conta linfocitaria CD4 + < 200/mmc
5. Classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults
6. Patient classification and cost analysis of AIDS and HIV: The case of Belgium
7. A model for calculating costs of hospital wards: An Italian experience
8. Costs of HIV medical care in the era of highly active antiretroviral therapy
9. A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less
10. Improved survival among HIV-infected individuals following initiation of atiretroviral therapy
11. Lifetime cost of human immunodeficiency virus-related health care
12. A Preliminary Study of Ritonavir, an Inhibitor of HIV-1 Protease, to Treat HIV-1 Infection
13. Changing patterns of mortality across Europe in patients infected with HIV-1
14. Decreased medical expenditure for care of HIV-seropositive patients. The impact of highly active antiretroviral therapy at a US Veterans Affairs Medical Center
15. La valutazione dei costi ospedalieri in un reparto di malattie infettive: Il caso degli Ospedali Riuniti di Bergamo
16. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection
17. AIDS scenario for the Netherlands; the economic impact on hospitals
18. How good are US studies of HIV costs of care?
19. Impact of combination therapy for HIV infection on inpatient census
20. The influence of socioeconomic status on health service utilisation by patients with AIDS in North Italy
21. Patients on highly active antiretroviral therapy (HAART) are more likely to remain employed in Italy